Finance Home - My Yahoo - Yahoo! - Help

Friday, January 8, 2010, 10:45AM ET - U.S. Markets close in 5 hours and 15 minutes. Dow  0.32% Nasdaq  0.09%

Bristol-Myers Squibb Co. (BMY)

At 10:30AM ET: 24.99   0.25 (0.99%)

MORE ON BMY

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Tue, Nov 3, 2009 • Cramer Finds Catalyst for Celgene's Stock at CNBC (Tue, Nov 3) • Cramer: The 8 Stocks That Control the Market at CNBC (Tue, Nov 3) • ViiV vows joint venture will help fight HIV at FT.com (Tue, Nov 3) • Cramer's 'Mad Money' Follow-Up: Nov. 3 at TheStreet.com (Tue, Nov 3) • [$$] High Yielders Get Lost in Rush Back to Risk at The Wall Street Journal Online (Tue, Nov 3) • [$$] 'Hope' Trade Still Has Legs at Barrons.com (Tue, Nov 3) • [$$] A Boxed-In Market at RealMoney by TheStreet.com (Tue, Nov 3) • Amylin Scores a Hat Trick at Motley Fool (Tue, Nov 3) • [video] 3 Stocks I Saw on TV at TheStreet.com (Tue, Nov 3) • Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com GlobeNewswire (Tue, Nov 3) • One Sign of a Strong Stock at Motley Fool (Tue, Nov 3) Mon, Nov 2, 2009 • A Cure for Cancer? at CNBC (Mon, Nov 2) • [video] Battling Cancer at CNBC (Mon, Nov 2) • Cramer's 'Mad Money' Recap: Bears Blinded by Negativity (Final) at TheStreet.com (Mon, Nov 2) • Cramer's 'Mad Money' Recap: Bears Blinded by Negativity (Update 3) at TheStreet.com (Mon, Nov 2) • Positive Phase III Data On XIFAXAN Will Drive Transformation Of Small GI Company According To Award Winning Piper Jaffrey Analyst Wall Street Transcript (Mon, Nov 2) • CEO Interview: Telik, Inc. - Dr. Michael M. Wick and Cynthia M. Butitta Wall Street Transcript (Mon, Nov 2) • Supreme Court Rejects Plavix Patent Challenge at The Wall Street Journal Online (Mon, Nov 2) • AMRI receives $750K milestone payment at bizjournals.com (Mon, Nov 2) • [$$] Fitz Bits: Steel Yourself for Downside in X at RealMoney by TheStreet.com (Mon, Nov 2) • Trading Review for Cell Therapeutics Incorporated Issued by Beacon Equity GlobeNewswire (Mon, Nov 2) • Peter Brimelow: Turnaround Letter not for faint of heart at MarketWatch (Mon, Nov 2) Sat, Oct 31, 2009 • BARACLUDE® (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis Business Wire (Sat, Oct 31) • Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C Business Wire (Sat, Oct 31) Fri, Oct 30, 2009 • Gilead: Transforming AIDS at Forbes.com (Fri, Oct 30) Older Headlines - Most Recent Headlines View headlines from: Fri, Oct 30, 2009Fri, Oct 23, 2009Fri, Oct 16, 2009Fri, Oct 9, 2009Fri, Oct 2, 2009Fri, Sep 25, 2009Fri, Sep 18, 2009Fri, Sep 11, 2009Fri, Sep 4, 2009Fri, Aug 28, 2009 Add BMY News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage